Boston Scientific Corp (BSX)

Operating return on assets (Operating ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	2,848,000	2,757,000	2,717,000	2,484,000	2,343,000	2,345,000	2,010,000	1,919,000	1,833,000	1,427,000	1,456,000	1,295,000	1,199,000	1,011,000	419,000	86,000	-138,000	80,000	668,000	1,123,000
Total assets	US$ in thousands	39,395,000	38,078,000	37,108,000	36,669,000	35,136,000	34,043,000	33,601,000	32,892,000	32,470,000	31,948,000	32,190,000	32,337,000	32,230,000	31,877,000	31,168,000	30,900,000	30,778,000	30,845,000	30,823,000	30,113,000
Operating ROA		7.23%	7.24%	7.32%	6.77%	6.67%	6.89%	5.98%	5.83%	5.65%	4.47%	4.52%	4.00%	3.72%	3.17%	1.34%	0.28%	-0.45%	0.26%	2.17%	3.73%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $2,848,000K ÷ $39,395,000K
= 7.23%

Operating return on assets (Operating ROA) for Boston Scientific Corp has shown a fluctuating trend over the past few years. Starting at 3.73% in March 2020, the ratio dropped significantly to -0.45% by December 2020, indicating operational inefficiencies or a decline in asset utilization. However, Boston Scientific managed to improve its performance, with the ratio gradually increasing to 7.23% by December 2024. This positive trend suggests that the company has been able to generate more operating income relative to its assets over time, reflecting potential improvements in operational efficiency and profitability. A consistent upward trajectory in the Operating ROA indicates effective management of assets and operations, which can be favorable for the company's overall financial performance and shareholder value.